Medicine and Dentistry
Ascorbic Acid
50%
Patient with Inflammatory Bowel Disease
50%
Tumor Necrosis Factor
50%
Crohn's Disease
41%
Patient with Crohn's Disease
36%
Gut
35%
Anti-Inflammatory Drug
32%
Inflammatory Bowel Disease
31%
Surgery
30%
Disease Course
28%
Microbiome
25%
Collagen Type 1
25%
Supplementation
25%
Stoma
25%
Biological Marker
25%
Infliximab
25%
Riboflavin
25%
Collagen Type 4
25%
Nicotinamide
25%
Vedolizumab
25%
Severe Acute Respiratory Syndrome Coronavirus 2
25%
Colon Crohn Disease
25%
C Reactive Protein
25%
Capillary Blood
25%
Disease
18%
Household
15%
Disease Exacerbation
15%
Placebo
13%
Finger
12%
Gut Microbiota
10%
Drug Megadose
10%
Vitamin B Group
10%
Nutritional Intervention
10%
Faecal Calprotectin
10%
Ulcerative Colitis
9%
mRNA Vaccine
9%
Infection
9%
Enteritis
8%
Blood Sampling
8%
Drug Therapy
7%
Immunosuppressive Drug
6%
Informed Consent
5%
Fistula
5%
Intervention Trial
5%
Finger Dermatoglyphics
5%
Collagen Degradation
5%
Granzyme B
5%
Hazard Ratio
5%
Recurrent Disease
5%
Stricture
5%
Keyphrases
Inflammatory Bowel Disease
50%
Health Development
25%
Type IV Collagen
25%
Type III Collagen
25%
Serum Biomarkers
25%
Collagen Turnover
25%
Vitamin B3
25%
Vedolizumab
25%
Vitamin C
25%
Vitamins
25%
Home-based
25%
Perianal Crohn's Disease
25%
Sampling Methods
25%
C-reactive Protein
25%
Infliximab
25%
Gut Health
25%
Vitamin C Supplementation
25%
Capillary Blood
25%
Targeted Release
25%
Self-sampling
25%
Vitamin B2
25%
Clinical Validation
25%
Tumor Necrosis Factor-α
25%
Stricture
25%
Production Process
25%
Type I Collagen
25%
Protein Concentration
25%
Crohn's Disease
20%
Penetrating Disease
15%
Disease Progression
15%
Tumour Necrosis Factor Inhibitor (TNFi)
12%
Finger Prick
12%
Collagen Formation
10%
SARS-CoV-2 Antibodies
10%
MRNA Vaccine
10%
Vaccination against SARS-CoV-2
10%
Montreal
10%
Multivariable
10%
Nicotinic Acid
8%
Targeted Delivery
8%
Lag Time
8%
Dissolution Test
8%
Anti-tumor Necrosis Factor Therapy
8%
Release Characteristics
8%
Innovative Therapies
8%
Particle Size Distribution
8%
Capillary Blood Sample
8%
Simulation System
8%
Coated Products
8%
Product Quality
8%
Immunology and Microbiology
Inflammatory Bowel Disease
100%
Tumor Necrosis Factor
75%
C-Reactive Protein
50%
Severe Acute Respiratory Syndrome Coronavirus 2
50%
Crohn's Disease
40%
Vaccination Policy
36%
Normal Human
29%
Immunoglobulin G Antibody
28%
Infliximab
25%
Capillary Blood
25%
Tumor Necrosis Factor Alpha
25%
Oxidative Stress
25%
Bacterial Population
25%
Vitamin C
25%
Intestine Flora
25%
Vedolizumab
25%
Antibody Response
25%
Stoma
25%
Antibody Titer
22%
Vaccine Efficacy
19%
Microflora
16%
Ulcerative Colitis
12%
Faecalibacterium prausnitzii
12%
Fluorescence in Situ Hybridization
12%
Drug Megadose
12%
Albumin Level
12%
Energy Metabolism
12%
Blood Sampling
10%
Immunosuppressive Drug
8%
Antibody Blood Level
8%
Monospecific Antibody
6%
Immunoassay
5%
Titer
5%
Spike
5%
Seroconversion
5%
